PMID: 9629953Jun 18, 1998Paper

Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania

Journal of Affective Disorders
J KnollT Suppes

Abstract

Gabapentin is an anticonvulsant proposed to have mood-stabilizing properties. It has been effective in the add-on treatment of refractory partial seizures and secondary generalized tonic-clonic seizures. It has the advantage of a favorable side effect profile and lack of drug interactions. Twelve consecutive outpatients with persistent, treatment-resistant bipolar spectrum disorders were treated with gabapentin in combination with other medications. Patients were started at 300 mg/day, which was titrated according to clinical response. Response was assessed every 3-4 weeks with a Clinical Global Improvement Scale. Dosage and side effects were noted. The median peak dose was 2400 mg/day. One patient had a marked response to gabapentin; seven, a moderate response; two, mild; and two, no response to treatment. Six patients discontinued treatment due to somatic complaints (i.e., sedation or fatigue). The most frequently reported adverse effect was sedation. Gabapentin was added openly, and rating was nonblind in this case series. The use of concomitant medications could have increased the amount of sedation experienced with gabapentin. Overall, gabapentin was associated with moderate improvement of mood symptoms. Given the severity...Continue Reading

References

May 1, 1995·The British Journal of Psychiatry : the Journal of Mental Science·C Short, L Cooke
Sep 1, 1995·The American Journal of Psychiatry·R Ryback, L Ryback
Jan 1, 1994·Epilepsia·L L RadulovicG R Erdman
Feb 15, 1993·European Journal of Pharmacology·N Suman-ChauhanG N Woodruff
Feb 15, 1993·European Journal of Pharmacology·D R HillG N Woodruff
Apr 1, 1997·Journal of Clinical Psychopharmacology·J BennettT Suppes

❮ Previous
Next ❯

Citations

Jan 30, 2002·Current Psychiatry Reports·William M McDonald, John Wermager
May 18, 2001·Journal of Affective Disorders·S N Ghaemi, F K Goodwin
Jun 5, 2003·Journal of Affective Disorders·Mauro Giovanni CartaBernardo Carpiniello
Oct 8, 1999·Journal of Affective Disorders·L T YoungR T Joffe
Feb 21, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Vasilis BozikasAthanasios Karavatos
Apr 15, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·I-Shin ShiahGlen B Baker
Dec 12, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·E VietaC Gastó
Jan 6, 2000·The Australian and New Zealand Journal of Psychiatry·P B Mitchell
Sep 18, 2001·Drugs·M BerkM Vorster
Jul 5, 2002·CNS Drugs·Kathryn J Macdonald, L Trevor Young
Oct 14, 2005·Paediatric Drugs·Arman Danielyan, Robert A Kowatch
Mar 21, 2001·Bipolar Disorders·L L AltshulerR Post
Mar 14, 2001·Journal of Affective Disorders·S YasminL H Price
Jan 13, 2016·Naunyn-Schmiedeberg's Archives of Pharmacology·Sattar OstadhadiAhmadReza Dehpour
Nov 7, 1999·The Psychiatric Clinics of North America·L SanchezR Weller
May 5, 2001·Expert Opinion on Pharmacotherapy·S Watson, A H Young
Oct 2, 2003·Expert Opinion on Investigational Drugs·Michael Berk, Seetal Dodd
Mar 10, 2006·Vision Research·Zhong-Lin LuBarbara Anne Dosher
Feb 13, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Heinz GrunzeUNKNOWN WFSBP Task Force on Treatment Guidelines for Bipolar Disorders
Jun 17, 2003·Journal of Geriatric Psychiatry and Neurology·M Awais SethiD P Devanand
Nov 27, 2001·British Medical Bulletin·I N Ferrier
Dec 5, 2008·Journal of Psychiatric Practice·Timothy S CareyCathy L Melvin
Nov 28, 2002·Journal of Clinical Psychopharmacology·Giulio PerugiHagop S Akiskal
Jun 1, 2000·Journal of Clinical Psychopharmacology·G E Brannon, P D Rolland
Oct 26, 2001·The Annals of Pharmacotherapy·I D Maidment

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here